Holen Sie sich die Stockscreener-App
32.15
0.74%
-0.24
Handel nachbörslich:
32.15
Schlusskurs vom Vortag:
$32.39
Offen:
$32.77
24-Stunden-Volumen:
1.02M
Relative Volume:
0.48
Marktkapitalisierung:
$3.42B
Einnahmen:
$741.17M
Nettoeinkommen (Verlust:
$104.65M
KGV:
36.73
EPS:
0.8752
Netto-Cashflow:
$162.57M
1W Leistung:
-5.08%
1M Leistung:
-19.56%
6M Leistung:
-55.88%
1J Leistung:
-41.39%
1-Tages-Spanne:
$31.81
$33.12
1-Wochen-Bereich:
$31.81
$34.27
52-Wochen-Spanne:
$28.66
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Firmenname
Corcept Therapeutics Inc
Sektor
Branche
Telefon
650.688.8803
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
32.15 | 3.45B | 741.17M | 104.65M | 162.57M | 0.8752 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-31 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | Eingeleitet | UBS | Neutral |
| 2025-11-18 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-06 | Hochstufung | Truist | Hold → Buy |
| 2023-04-11 | Eingeleitet | SVB Securities | Market Perform |
| 2023-04-04 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-01 | Herabstufung | Truist | Buy → Hold |
| 2022-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-27 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-24 | Eingeleitet | Jefferies | Buy |
| 2019-09-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-04 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Bestätigt | Stifel | Hold |
| 2018-05-31 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-09 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Eingeleitet | Stifel | Buy |
| 2017-02-02 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-04-21 | Eingeleitet | FBR Capital | Outperform |
| 2014-01-13 | Herabstufung | Stifel | Buy → Hold |
| 2013-08-09 | Herabstufung | Janney | Buy → Neutral |
| 2013-08-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-01-06 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Hochstufung | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Alle ansehen
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics - GlobeNewswire
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming DeadlinesCORT - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements - TipRanks
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ... - Bluefield Daily Telegraph
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT - GlobeNewswire
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Lawsuit filed for Investors who lost money with shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) - openPR.com
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - GlobeNewswire Inc.
ROSEN, A LEADING NATIONAL FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel ... - Bluefield Daily Telegraph
H.C. Wainwright Cuts Corcept Therapeutics Incorporated (CORT) Price Target, Keeps Buy Rating - Yahoo Finance
Corcept Therapeutics Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
CORT LAWSUIT ALERT: Levi & Korsinsky Notifies Corcept Therapeuti - GuruFocus
CORCEPT THERAPEUTICS INCORPORATED (CORT) DEADLINE ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline - ACCESS Newswire
First Trust Advisors LP Purchases 183,038 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
CORT Investors Have Opportunity to Lead Corcept Therapeutics Inc - GuruFocus
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - GlobeNewswire
Corcept Therapeutics Incorporated Securities Fraud Class - GlobeNewswire
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit - ChartMill
Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines - marketscreener.com
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026 - Business Wire
CORT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT - ChartMill
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline – Company AnnouncementFT.com - Financial Times
Relacorilant safe, works to control high blood pressure in Cushing’s: Study - Cushing's Disease News
Bronstein, Gewirtz & Grossman LLC Urges Corcept - GlobeNewswire
Important Notice to Long-Term Shareholders of Boston - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Corcept Therapeutics Incorporated LawsuitCORT - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Dimensional Fund Advisors LP Reduces Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Contact Levi & Korsinsky by April 21, 2026 Deadline to Join - GlobeNewswire
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors - GlobeNewswire
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit – Company AnnouncementFT.com - Financial Times
User - The Chronicle-Journal
CORT INVESTOR REMINDER: Corcept Therapeutics Incorporated Investors Have Until April 21, 2026 To Seek Lead Plaintiff Role - ACCESS Newswire
CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire
Class Action Filed Against Corcept Therapeutics - GlobeNewswire
Corcept Therapeutics (CORT) Litigation: Hagens Berman - GlobeNewswire
Corcept Therapeutics Class Action Reminder for Investors - Intellectia AI
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Corcept Therapeutics Incorporated to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Corcept - GlobeNewswire
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline (2026-03-05) - Seeking Alpha
Why Is CORT Stock Falling Today? - Stocktwits
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT) - ACCESS Newswire
Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):